NCT05430893 (PUBATOX) is a clinical trial of Botulinum Toxin A in Athletic Pubalgia, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT05430893?

NCT05430893 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT05430893?

Interventions in NCT05430893: Botulinum Toxin A.

What condition does NCT05430893 study?

NCT05430893 studies Athletic Pubalgia.

Is NCT05430893 still recruiting?

NCT05430893 is currently completed. Last updated 15 September 2025.

Last reviewed 2025-09-15 · How we verify

NCT05430893: PUBATOX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia

Completed Last updated 15 September 2025

What this trial tests

trial testing Botulinum Toxin A in Athletic Pubalgia in 20 participants. Completed in 31 March 2021.

Timeline

1 June 2017

Primary endpoint
31 March 2021

31 March 2021

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 June 2017
Primary completion	31 March 2021
Estimated completion	31 March 2021
Sites	1 location across France

Drugs / interventions tested

Botulinum Toxin A — full drug profile →

Conditions studied

Athletic Pubalgia — all drugs for Athletic Pubalgia →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Athletic Pubalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic athletic pubalgia is a frequent sport condition in which the effectiveness of medical treatment has not been proven. Intra-muscular injection of botulinum toxin A may have positive effects on pain in some chronic tendinitis. The investigators hypothesized that similar analgesic effect of intra-muscular botulinum toxin A may be observed in individuals with chronic AP. In the present study, the investigators aimed to describe the short-term evolution of pain and of activity limitations and quality of life, after an injection of the adductor longus with botulinum toxin A, in individuals with chronic AP, for whom medical and/or surgical treatments have failed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intra-muscular botulinum toxin A in chronic athletic pubalgia: a retrospective observational study
Orhan J, Garofoli R, Alperin É, Ladauge F, et al · · 2022 · DOI 10.21203/rs.3.rs-1824418/v1

Verify or expand the search:

Other trials of Botulinum Toxin A

Trials testing the same drug.

NCT06807164 — Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome · Phase 2 · recruiting
NCT06684249 — Efficacy of Nerve Block Versus Botox in Chronic Migraine Management · NA · recruiting
NCT05426161 — The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities · Phase 4 · completed
NCT05367271 — The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis · Phase 2, PHASE3 · completed
NCT06392633 — SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS: RANDOMIZED TRIAL · NA · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05430893 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 15 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05430893.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing